Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

Authors

Nathalie Scholler, Gilead Sciences
Armin Ghobadi, Washington University School of Medicine in St. Louis
et al

Journal

Nature Medicine

Publication Date

9-2022

Volume

28

Issue

9

First Page

1872

Last Page

1882

Document Type

Open Access Publication

DOI

10.1038/s41591-022-01916-x

Rights and Permissions

Scholler, N., Perbost, R., Locke, F.L. et al. Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma. Nat Med 28, 1872–1882 (2022). https://doi.org/10.1038/s41591-022-01916-x This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Scholler, Nathalie; Ghobadi, Armin; and et al, "Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma." Nature Medicine. 28, 9. 1872 - 1882. (2022).
https://digitalcommons.wustl.edu/oa_4/341